Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 9/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3900452 | 0.89 | ACHE (0.45) | ACHEMEN1KMT2ASMN1; SMN2HPGD | |
| SCHEMBL3899768 | 0.88 | ACHE (0.43) | ACHESLC6A3SMN1; SMN2HPGD | |
| SCHEMBL3909908 | 0.88 | ACHE (0.44) | ACHECYP3A4TSHRCASP3HPGD | |
| SCHEMBL3902804 | 0.86 | ALDH1A1 (0.36) | ACHETSHRSMN1; SMN2HPGD | |
| SCHEMBL3905199 | 0.86 | SLC6A2 (0.41) | ACHEMEN1KMT2ASLC6A3CYP3A4 | |
| SCHEMBL3908430 | 0.85 | ACHE (0.33) | ACHECA1CA2CA4CA7 | |
| SCHEMBL3899791 | 0.85 | ACHE (0.39) | ACHECYP3A4AKR1C3AKR1C2 | |
| SCHEMBL3897271 | 0.84 | JAK3 (0.36) | ACHECYP3A4TSHRSMN1; SMN2HPGD | |
| SCHEMBL1415795 | 0.73 | ACHE (0.44) | ACHEMEN1KMT2ASLC6A3CASP3 | |
| SCHEMBL17629476 | 0.71 | ACHE (0.41) | ACHEMEN1KMT2ASLC6A3CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0632106-B2 | Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MFG CO (JP) | 2009-02-25 | — | — | EP | disclosed |
| EP-0632106-B1 | Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MFG CO (JP) | 2001-08-22 | — | — | EP | disclosed |
| US-5817817-A | Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MANUFACTURING CO., LTD. (JP) | 1998-10-06 | — | — | US | disclosed |
| US-5659036-A | Process for the production of 2,5-di(arylamino)-3,6-dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MANUFACTURING CO., LTD. (JP) | 1997-08-19 | — | — | US | disclosed |
| EP-0632106-A1 | Process for the production of 2,5-di(arylamino)-3,6- dihydroterephthalic acid dialkyl ester, and process for the production of quinacridone from said ester as intermediate | TOYO INK MANUFACTURING CO., LTD. (JP) | 1995-01-04 | — | — | EP | disclosed |